The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis, l

NEAT Investigators; SCTBG Investigators

The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis, l

NEAT Investigators, SCTBG Investigators

Cancer and Genomic Sciences

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Publication status	Published - 1 Jan 2007
Event	43rd Annual American Society of Clinical Oncology Meeting, chicago, Illinois USA - Duration: 1 Jan 2007 → …

Conference

Conference	43rd Annual American Society of Clinical Oncology Meeting, chicago, Illinois USA
Period	1/01/07 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{0b15c97a41db4cc4b18187b43534ac9e,

title = "The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis, l",

author = "HM Earl and L Hiller and JA Dunn and Sarah Bathers and RJ Grieve and David Spooner and RK Agrawal and L Foster and C Twelves and CJ Poole and {NEAT Investigators} and {SCTBG Investigators}",

year = "2007",

month = jan,

day = "1",

language = "English",

note = "43rd Annual American Society of Clinical Oncology Meeting, chicago, Illinois USA ; Conference date: 01-01-2007",

}

The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis, l. / NEAT Investigators; SCTBG Investigators.
2007. Abstract from 43rd Annual American Society of Clinical Oncology Meeting, chicago, Illinois USA.

Research output: Contribution to conference (unpublished) › Abstract

TY - CONF

T1 - The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis, l

AU - Earl, HM

AU - Hiller, L

AU - Dunn, JA

AU - Bathers, Sarah

AU - Grieve, RJ

AU - Spooner, David

AU - Agrawal, RK

AU - Foster, L

AU - Twelves, C

AU - Poole, CJ

AU - NEAT Investigators

AU - SCTBG Investigators

PY - 2007/1/1

Y1 - 2007/1/1

M3 - Abstract

T2 - 43rd Annual American Society of Clinical Oncology Meeting, chicago, Illinois USA

Y2 - 1 January 2007

ER -